2022 AAOGF Travel Award

Deadline: June 1, 2022

Click here to see past recipients

Click here for an overview

Click here to visit the AAOGF Travel Award website

The American Association of Obstetricians and Gynecologists Foundation (AAOGF) and The American Gynecological and Obstetrical Society (AGOS) are pleased to announce that AAOGF will provide travel awards of up to $2,000 each to be used for the AGOS Annual Meeting to be held in 2022. The home Department of each recipient must agree to provide the balance of support required for attendance.

Guidelines for Eligibility:

  • Application must have an MD or DO degree and must have successfully completed residency in OBGyn
  • Full-time academic faculty position.
  • Primary appointment in a Medical School Department of Obstetrics and Gynecology in North America.
  • Applicants may not be in subspecialty training.
  • Applicants may not be an active candidate for membership in AGOS.
  • CV indicating progressive scholarly productivity, substantial promise for future academic/scholarly contributions, and potential for membership in AGOS.
  • Recipients must commit to attend the entire meeting including all of the scientific sessions.
  • May NOT be a prior recipient of an AAOGF/AGOS Travel Award.
  • Current and former AAOGF scholars are encouraged to apply.


Application Packet MUST Include:

  • Nomination letter by a member of AGOS.
  • Accompanying letter from the candidate’s Department Chair indicating that the balance of support will be provided by the Department.
  • Current CV (including any prior and current grant support).

Applicants must register for the AGOS meeting in advance. Registration fees will be paid by AAOGF as part of the grant.

Applications for Travel Awards are due June 1, 2022.

Mail or email to attention: Shelby Smiley using the address information below:

Shelby Smiley
Administrator
American Association of Obstetricians & Gynecologists Foundation
2331 Rock Spring Rd.
Forest Hill, MD 21050
Phone: (443) 640-1059 Ext. 1253
ssmiley@stringfellowgroup.net

Warner K. Huh

Warner K. Huh, MD, MSHA is Chair of the Department of Obstetrics and Gynecology and holds the Charles E. Flowers, Jr. Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB). He is also Professor in the Department of Surgery and Professor in the Department of Epidemiology in the UAB School of Public Health. He was previously the Division Director of Gynecologic Oncology, Vice Chair of Gynecology, and Chief Medical Officer of the UAB Cancer Service Line/O’Neal Comprehensive Cancer Center. His research interests include screening and prevention of HPV related diseases as well as novel immunotherapeutic approaches for pre-invasive disease of the cervix as well as cervical cancer. He has authored or co-authored over 300 articles in journals including The New England Journal of Medicine, Lancet, Lancet Oncology, Journal of the National Cancer Institute Cancer, Clinical Cancer Research, Gynecologic Oncology, Obstetrics & Gynecology, and the American Journal of Obstetrics & Gynecology (h-index: 70). Dr. Huh serves as co-PI (MPI) of the Johns Hopkins-UAB-University of Colorado Cervical Cancer Specialized Programs of Research Excellence (SPORE) program (2P50CA098252-06A1) – one of the most enduring SPORE programs in the NCI. Further, he is PI on a cervical cancer prevention R01 grant through the NCI (5R01CA279021). Dr. Huh serves as a Deputy Editor of Gynecologic Oncology and serves as an Associate Editor of The Journal of Lower Genital Tract Disease. He is on the steering committee for the ASCCP treatment guidelines and was co-chair of the ASCCP colposcopy standards effort. He is Past President of the Society of Gynecologic Oncology (SGO) and ASCCP. He is currently serves on the American Board of Obstetrics and Gynecology (ABOG) Division of Gynecologic Oncology. He recently completed the Executive Master of Science in Health Administration (MSHA) Program at UAB (2022-2024). He co-leads OPERATION WIPEOUT- the only state-based cervical cancer elimination effort in the United States.